Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025)

Eton Pharmaceuticals has disclosed Change in Accured Expenses across 8 years of filings, most recently posting $426000.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $426000.0, down 79.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 million (down 31.87% YoY), and the FY2025 annual result was $1.0 million, down 31.87% from the prior year.
• Change in Accured Expenses came in at $426000.0 for Q4 2025 at Eton Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q4 2024 to a low of -$1.6 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $397000.0 (2021), against an average of $326850.0.
• Across the five-year window, Change in Accured Expenses surged 4230.0% in 2023 and plunged 232.28% in 2024, its largest moves.
• Eton Pharmaceuticals' Change in Accured Expenses stood at $120000.0 in 2021, then slumped by 153.33% to -$64000.0 in 2022, then surged by 2246.88% to $1.4 million in 2023, then jumped by 48.69% to $2.0 million in 2024, then plunged by 79.15% to $426000.0 in 2025.
• The last three Change in Accured Expenses figures came in at $426000.0 (Q4 2025), $1.8 million (Q3 2025), and $172000.0 (Q2 2025), per Business Quant data.